Public trial registry of the CCC-Munich

Trial ADAPTlate

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ADAPTlate
World
Full title
:

A randomized, controlled, open-label, phase-III trial on Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high risk, HR+/HER2- early breast cancer

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Frauenklinik IN, Telefon: 089440054111
Indications
Classification Code Description
ICD-10-GM C50.- Bösartige Neubildung der Brustdrüse [Mamma]
- Breastcancer
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2027-12-31 / Unknown
Participants
Function Prename Surname Organization
World Principal Investigator NADIA HARBECK Keine Organisationseinheit angegeben Magnifier